151 related articles for article (PubMed ID: 25726061)
1. Novel targets in pancreatic cancer research.
Kozak G; Blanco FF; Brody JR
Semin Oncol; 2015 Feb; 42(1):177-87. PubMed ID: 25726061
[TBL] [Abstract][Full Text] [Related]
2. Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.
Kajihara M; Takakura K; Kanai T; Ito Z; Matsumoto Y; Shimodaira S; Okamoto M; Ohkusa T; Koido S
World J Gastroenterol; 2016 May; 22(18):4446-58. PubMed ID: 27182156
[TBL] [Abstract][Full Text] [Related]
3. Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in Pancreatic Cancer.
Ravichandran M; Hu J; Cai C; Ward NP; Venida A; Foakes C; Kuljanin M; Yang A; Hennessey CJ; Yang Y; Desousa BR; Rademaker G; Staes AAL; Cakir Z; Jain IH; Aguirre AJ; Mancias JD; Shen Y; DeNicola GM; Perera RM
Cancer Discov; 2022 Sep; 12(9):2198-2219. PubMed ID: 35771494
[TBL] [Abstract][Full Text] [Related]
4. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.
Daley D; Mani VR; Mohan N; Akkad N; Ochi A; Heindel DW; Lee KB; Zambirinis CP; Pandian GSB; Savadkar S; Torres-Hernandez A; Nayak S; Wang D; Hundeyin M; Diskin B; Aykut B; Werba G; Barilla RM; Rodriguez R; Chang S; Gardner L; Mahal LK; Ueberheide B; Miller G
Nat Med; 2017 May; 23(5):556-567. PubMed ID: 28394331
[TBL] [Abstract][Full Text] [Related]
5. Circadian transcriptome of pancreatic adenocarcinoma unravels chronotherapeutic targets.
Sharma D; Adnan D; Abdel-Reheem MK; Anafi RC; Leary DD; Bishehsari F
JCI Insight; 2024 May; 9(9):. PubMed ID: 38716727
[TBL] [Abstract][Full Text] [Related]
6. Critical role for arginase 2 in obesity-associated pancreatic cancer.
Zaytouni T; Tsai PY; Hitchcock DS; DuBois CD; Freinkman E; Lin L; Morales-Oyarvide V; Lenehan PJ; Wolpin BM; Mino-Kenudson M; Torres EM; Stylopoulos N; Clish CB; Kalaany NY
Nat Commun; 2017 Aug; 8(1):242. PubMed ID: 28808255
[TBL] [Abstract][Full Text] [Related]
7. The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.
Biancur DE; Kimmelman AC
Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):67-75. PubMed ID: 29702208
[TBL] [Abstract][Full Text] [Related]
8. Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic.
Rodríguez Gil Y; Jiménez Sánchez P; Muñoz Velasco R; García García A; Sánchez-Arévalo Lobo VJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669845
[TBL] [Abstract][Full Text] [Related]
9. Altered glycosylation in pancreatic cancer and beyond.
Lumibao JC; Tremblay JR; Hsu J; Engle DD
J Exp Med; 2022 Jun; 219(6):. PubMed ID: 35522218
[TBL] [Abstract][Full Text] [Related]
10. The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular.
Deng J; Guo Y; Du J; Gu J; Kong L; Tao B; Li J; Fu D
Front Cell Dev Biol; 2022; 10():844028. PubMed ID: 35252207
[TBL] [Abstract][Full Text] [Related]
11. Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.
Teague A; Lim KH; Wang-Gillam A
Ther Adv Med Oncol; 2015 Mar; 7(2):68-84. PubMed ID: 25755680
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.
Garrido-Laguna I; Hidalgo M
Nat Rev Clin Oncol; 2015 Jun; 12(6):319-34. PubMed ID: 25824606
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
Witkiewicz AK; McMillan EA; Balaji U; Baek G; Lin WC; Mansour J; Mollaee M; Wagner KU; Koduru P; Yopp A; Choti MA; Yeo CJ; McCue P; White MA; Knudsen ES
Nat Commun; 2015 Apr; 6():6744. PubMed ID: 25855536
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer: The microenvironment needs attention too!
Apte MV; Xu Z; Pothula S; Goldstein D; Pirola RC; Wilson JS
Pancreatology; 2015 Jul; 15(4 Suppl):S32-8. PubMed ID: 25845856
[TBL] [Abstract][Full Text] [Related]
15. New challenges in perioperative management of pancreatic cancer.
Puleo F; Maréchal R; Demetter P; Bali MA; Calomme A; Closset J; Bachet JB; Deviere J; Van Laethem JL
World J Gastroenterol; 2015 Feb; 21(8):2281-93. PubMed ID: 25741134
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
Tanaka S
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S197-205. PubMed ID: 25749932
[TBL] [Abstract][Full Text] [Related]
17. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.
Frampton AE; Krell J; Jamieson NB; Gall TM; Giovannetti E; Funel N; Mato Prado M; Krell D; Habib NA; Castellano L; Jiao LR; Stebbing J
Eur J Cancer; 2015 Jul; 51(11):1389-404. PubMed ID: 26002251
[TBL] [Abstract][Full Text] [Related]
18. Stromal biology and therapy in pancreatic cancer: a changing paradigm.
Neesse A; Algül H; Tuveson DA; Gress TM
Gut; 2015 Sep; 64(9):1476-84. PubMed ID: 25994217
[TBL] [Abstract][Full Text] [Related]
19. Metastatic pancreatic cancer: Is there a light at the end of the tunnel?
Vaccaro V; Sperduti I; Vari S; Bria E; Melisi D; Garufi C; Nuzzo C; Scarpa A; Tortora G; Cognetti F; Reni M; Milella M
World J Gastroenterol; 2015 Apr; 21(16):4788-801. PubMed ID: 25944992
[TBL] [Abstract][Full Text] [Related]
20. Progress in the treatment of metastatic pancreatic cancer and the search for next opportunities.
Ko AH
J Clin Oncol; 2015 Jun; 33(16):1779-86. PubMed ID: 25918299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
